ABOUT THE SPEAKERS

Jason Callahan, Chief Nuclear Medicine Technologist, Melbourne Theranostics Innovation Centre (MTIC)

Dr Jason Callahan is a Nuclear Medicine Technologist with over 20 years of experience in Nuclear Medicine and Molecular Imaging. A er completing his training at the Austin Hospital in Melbourne he took up a position at the Mount Elizabeth Hospital in Singapore to help establish one of the first PET/CT services in South East Asia. On returning to Melbourne, he worked at the Royal Melbourne Hospital where his first interest in research began through the investigation of drainage pa erns in lymphoscintigraphy. In 2008, Jason accepted a position at the Peter MacCallum Cancer Centre as the Technical Supervisor in the Centre for Molecular Imaging and Therapeutic Nuclear Medicine. During nearly 15 years with PeterMac Jason completed his PhD investigating the clinical application of advanced PET/CT imaging techniques as well as coordinated the central imaging review for over 20 international multicentre clinical trials. Jason has over 100 peer reviewed publications with nearly 3000 citations in the use of Molecular imaging in a wide range of oncologic indications. In 2022, Jason was appointed as the Chief Nuclear Medicine Technologist at the Melbourne Theranostic Innovation Centre with the goal of advancing the use of Molecular Imaging and Therapeutic Nuclear Medicine in improving the lives of people living with cancer.

Duncan Veysey, Deputy Chief MIT/Chief NMT, Royal Children's Hospital

Duncan is the Chief Nuclear Medicine and PET Technologist, and Deputy Chief Medical Imaging Technologist at The Royal Children’s Hospital (RCH) Melbourne. Duncan graduated RMIT (B. App. Sci – Nuclear Medicine) in 2003 and has worked at RCH for over 17 years.

With specific interests of improving radiation dosimetry and holistic paediatric healthcare provision, Duncan has presented and published to a variety of local and international audiences, most recently focussing on paediatric PET/MRI. Commi ing to hybrid imaging and minimizing radiation exposure to children, RCH installed a PET/MRI in 2016, and Duncan has helped lead a passionate team become the leading site of clinical paediatric PET/MRI studies worldwide.

Sarah Stephenson, Molecular Imaging Product Manager, Siemens

Sarah is a molecular imaging product manager and research collaborations manager with Siemens. She is based in Adelaide but her role covers Australia and New Zealand. Sarah has over 20 years clinical experience in both the public and private sectors. Most recently she was working as a technologist at Royal Adelaide Hospital where she was involved in the clinical educator work there in conjunction with working at University of South Australia as the Nuclear Medicine student clinical supervisor. Prior to that she held a team leader technologist role at Royal Brisbane and Women’s Hospital where she was heavily involved in PET and research activities. She’s always been actively involved in the ANZSNM and was branch secretary in Queensland for a number of years.